ANLN and lung adenocarcinoma: Interestingly, PTTG1, DLGAP5, and ANLN were also included in the metabolically relevant prognostic and immunotherapeutic profiles of lung adenocarcinoma in a recent study (71), suggesting that the relevant prognostic profiles that we constructed do indeed reflect the metabolic profiles of lung adenocarcinoma at the transcriptional level to some extent.